Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Savara brings in $833k so far through its Series A round; exceeds $1.4mm

Executive Summary

Savara (pulmonary drug delivery) has raised at least $833k of a proposed $1.4mm Series A venture round. There were 13 investors, most of whom are current shareholders. A second tranche may close later this year.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies